日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Correction: Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy

更正:肿瘤抑制因子LKB1/STK11的缺失揭示了一种瘦素介导的对线粒体解偶联剂的敏感性机制,可用于靶向癌症治疗

Angelopoulou, Andriani; Theocharous, Giorgos; Valakos, Dimitrios; Polyzou, Aikaterini; Magkouta, Sophia; Myrianthopoulos, Vassilios; Havaki, Sophia; Fiorillo, Marco; Tremi, Ioanna; Vachlas, Konstantinos; Nisotakis, Theodoros; Thanos, Dimitris-Foivos; Pantazaki, Anastasia; Kletsas, Dimitris; Bartek, Jiri; Petty, Russell; Thanos, Dimitris; McCrimmon, Rory J; Papaspyropoulos, Angelos; Gorgoulis, Vassilis G

Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma

更正:相对端粒长度和衰老相关炎症细胞因子作为晚期或可切除胃食管腺癌患者的血液预后标志物

Bilsland, Alan E; McCulloch, Eilidh; Degerman, Sofie; Landfors, Mattias; Wadsley, Jon; Wall, Lucy; Thompson, Catherine; Damyanova, Iva; Samuel, Leslie; Petty, Russell; Jain, Ankit; Lewsley, Liz-Anne; MacMillan, Antonia; MacLeod, Martin; Walker, Jennifer; McCormick, Carol; McCartney, Elaine; Roxburgh, Patricia; Stobo, Jamie; Thomson, Fiona; Evans, T R Jeffry; Keith, W Nicol

Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma

相对端粒长度和衰老相关炎症细胞因子作为晚期或可切除胃食管腺癌患者的血液预后标志物

Bilsland, Alan E; McCulloch, Eilidh; Degerman, Sofie; Landfors, Mattias; Wadsley, Jon; Wall, Lucy; Thompson, Catherine; Damyanova, Iva; Samuel, Leslie; Petty, Russell; Jain, Ankit; Lewsley, Liz-Anne; MacMillan, Antonia; MacLeod, Martin; Walker, Jennifer; McCormick, Carol; McCartney, Elaine; Roxburgh, Patricia; Stobo, Jamie; Thomson, Fiona; Evans, T R Jeffry; Keith, W Nicol

Immune cell senescence drives responsiveness to immunotherapy in melanoma.

免疫细胞衰老驱动黑色素瘤对免疫疗法的反应。

Pantelis Pavlos, Tremoulis Dimitrios Christos, Evangelou Konstantinos, Bakouros Panagiotis, Magkouta Sophia, Ntintas Orestis A, Veroutis Dimitris, Theocharous Giorgos, Kostopoulos Ioannis V, Thanos Dimitris-Foivos, Chatziioannou Eftychia, Anastasiou Ioanna A, Lagopati Nefeli, Valakos Dimitrios, Skaltsas Dimitrios, Pop Oltin Tiberiu, Abdou Marie Therese, Gagos Sarantis, Kletsas Dimitris, Thanos Dimitris, Stratigos Alexandros J, Röcken Martin, Flatz Lukas, Chrousos George P, Vlachakis Dimitrios, Tsitsilonis Ourania E, Petty Russell, Karamitros Timokratis, Gorgoulis Vassilis G

Research priorities for cancers of the oesophagus and stomach: recommendations from a UK and Ireland patient and healthcare professional partnership exercise

食管癌和胃癌研究重点:英国和爱尔兰患者及医疗保健专业人员合作演练的建议

Jones, Christopher M; Ng, Wee Han; Tincknell, Laura; McClurg, Dylan P; Adam, Emily; Bhandari, Pradeep; Campbell, Karen; Chambers, Pinkie; Ciccarelli, Francesca; Coleman, Helen G; Crosby, Tom; Doyle, Carmel; Dunn, Jason M; Elliott, Jessie; Fitzgerald, Rebecca C; Foley, Kieran G; Goh, Vicky; Grabsch, Heike I; Graham, Trevor A; Grocott, Mike; Gwynne, Sarah; Harvey, Jo; Jansen, Marnix; Lagergren, Pernilla; Lamb, Claire; Leigh-Doyle, Lauren; Malik, Farida; Mayland, Catriona; McCord, Mimi; Moss, Alan; Mukherjee, Somnath; Petty, Russell; Rananaware, Siddharth; Reid, Joanne; Rubin, Gregory; Smyth, Elizabeth; Trudgill, Nigel J; Turkington, Richard C; Underwood, Timothy J; Walter, Fiona M; Williams, Jessica; Peters, Christopher J

AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer.

AREG 和 EREG 是胃食管癌中 EGFR 抑制剂疗效的预测生物标志物

Conticelli Daniela, Volante Marco, Pietrantonio Filippo, Orrù Claudia, Olivero Martina, Nottegar Alessia, Borghi Felice, Baiocchi Gian L, Crotti Giovanni, Fumagalli Romario Uberto, De Manzoni Giovanni, Reddavid Rossella, Porporato Roberta, Kılıç Dinçer, Ghione Rebecca, Calabrò Erika, Petty Russell, Corso Simona, Giordano Silvia, Migliore Cristina

AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma

AKT/mTOR作为可靶向的枢纽,有望克服食管鳞状细胞癌对EGFR抑制剂的多模式耐药性

Spender, Lindsay C; Watt, Dale M; Baxter, Mark A; Shuttleworth, Morven K; Walker, Kateah; Savage, Alice R; Clements, Hollie A; Kapelyukh, Yury; Bray, Susan E; King, Sharon I; Wolf, C Roland; Inman, Gareth J; Walsh, Shaun V; Blyth, Karen; Petty, Russell D

Interrogating the regulatory epigenome of cellular senescence

探究细胞衰老的调控表观基因组

Thanos, Dimitris-Foivos; Ntintas, Orestis A; Athanasiadis, Emmanouil I; Papaspyropoulos, Angelos; Petty, Russell; Gorgoulis, Vassilis G

N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP)-A Prognostic Biomarker in Older and/or Frail Adults with Advanced Gastroesophageal Cancer: A Post Hoc Analysis of the GO2 Clinical Trial

N端脑钠肽前体(NT-proBNP)——老年和/或体弱晚期胃食管癌患者的预后生物标志物:GO2临床试验的事后分析

Tao, Yuewei; Lang, Chim C; Petty, Russell D; Hall, Peter S; Baxter, Mark A

Clinical and pharmacogenomic predictors of survival in tamoxifen treated breast cancer female patients: a real-world study

他莫昔芬治疗乳腺癌女性患者生存的临床和药物基因组学预测因子:一项真实世界研究

Al-Matrafi, Abdullah R; Bedair, Khaled F; Srinivasan, Sundararajan; Palmer, Colin; Campbell, Archie; Hayward, Caroline; Pearson, Ewan R; Petty, Russell D